Radcliffe Department of Medicine, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom; and Kansas City, Missouri, USA.
Stowers Institute for Medical Research, Kansas City, Missouri, USA.
CRISPR J. 2022 Oct;5(5):642-659. doi: 10.1089/crispr.2022.0052. Epub 2022 Oct 7.
CRISPR-Cas9 has emerged as a major genome manipulation tool. As Cas9 can cause off-target effects, several methods for controlling the expression of CRISPR systems were developed. Recent studies have shown that CRISPR activity could be controlled by sensing expression levels of endogenous transcripts. This is particularly interesting, as endogenous RNAs could harbor important information about the cell type, disease state, and environmental challenges cells are facing. Single-guide RNA (sgRNA) engineering played a major role in the development of RNA-responsive CRISPR systems. Following further optimizations, RNA-responsive sgRNAs could enable the development of novel therapeutic and research applications. This review introduces engineering strategies that could be employed to modify sgRNAs with a focus on recent advances made toward the development of RNA-responsive sgRNAs. Future directions and potential applications of these technologies are also discussed.
CRISPR-Cas9 已经成为一种主要的基因组操作工具。由于 Cas9 可能会引起脱靶效应,因此开发了几种控制 CRISPR 系统表达的方法。最近的研究表明,CRISPR 的活性可以通过感应内源性转录本的表达水平来控制。这一点特别有趣,因为内源性 RNA 可能包含有关细胞类型、疾病状态以及细胞面临的环境挑战的重要信息。单指导 RNA(sgRNA)工程在 RNA 响应性 CRISPR 系统的发展中发挥了重要作用。经过进一步优化,RNA 响应性 sgRNA 可以为新型治疗和研究应用的开发提供可能。本文综述了用于修饰 sgRNA 的工程策略,重点介绍了开发 RNA 响应性 sgRNA 方面的最新进展。还讨论了这些技术的未来方向和潜在应用。